Track topics on Twitter Track topics that are important to you
MONTERREY, Mexico, June 2, 2015 (GLOBE NEWSWIRE) -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (Nasdaq:OMAB) (BMV:OMA), announces that it has engaged UBS Casa de Bolsa, S.A. de C.V., UBS Grupo Financiero as a market maker for its shares.
UBS, in its role as market maker, will trade OMA Series B shares listed on the Mexican Stock Exchange in order to promote liquidity, set reference prices, and contribute to the stability of the same, in accordance with applicable laws and norms.
By incorporating the market maker program, along with the share purchase fund authorized by the Annual Shareholders' Meeting, OMA reaffirms its commitment to investors to promote the trading volume and liquidity of its shares.
The contract is in effect from June 2 through December 31, 2016, and is renewable with the agreement of the parties.
Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA, operates 13 international airports in nine states of central and northern Mexico. OMA's airports serve Monterrey, Mexico's third largest metropolitan area, the tourist destinations of Acapulco, Mazatlán, and Zihuatanejo, and nine other regional centers and border cities. OMA also operates a hotel inside Terminal 2 of the Mexico City airport. OMA employs over 1,000 persons in order to offer passengers and clients, airport and commercial services in facilities that comply with all applicable international safety, security standards, and ISO 9001:2008. OMA's strategic shareholder members are ICA, Mexico's largest engineering, procurement, and construction company, and Aéroports de Paris Management, subsidiary of Aéroports de Paris, the second largest European airports operator. OMA is listed on the Mexican Stock Exchange (OMA) and on the NASDAQ Global Select Market (OMAB). For more information, visit
CONTACT: OMA Headquarters: +52.81.8625.4300 Chief Financial Officer Jose Luis Guerrero Cortes firstname.lastname@example.org Ext.308 Investor Relations in USA: Daniel Wilson / Zemi Communications email@example.com +1.212.689.9560 Investor Relations in Mexico Vicsaly Torres / firstname.lastname@example.org / +52 81 8625 4309 Emmanuel Camacho / email@example.com / +52 81 8625 4308 Manuel Higinio de Leon / firstname.lastname@example.org / +52 81 8625 4334NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...